SS 41 - GU 5: Novel Prognostic Tools in Prostate Cancer

Moderator(s)

• 

  Adam Olson, MD, MS

  UPMC Hillman Cancer Center
  Pittsburgh, PA
• 

  Angela Jia, MD, PhD

  Case Western Reserve University/University Hospitals Cleveland Medical Center
  Cleveland, OH

Presentations:

• 8:00 AM – 8:10 AM ET

  Validation of a Digital Pathology-Based Multimodal Artificial Intelligence Model in Oliogmetastatic Castration-Sensitive Prostate Cancer, including in Patients from the STOMP and ORIOLE Phase II Rando
  

  Presenter: Philip Sutera, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center
• 8:10 AM – 8:20 AM ET

  A Digital Pathology Multimodal Artificial Intelligence Algorithm is Associated with Pro-Metastatic Genomic Pathways in Oligometastatic Prostate Cancer
  

  Presenter: Yang Song, PhD – University of Maryland
• 8:20 AM – 8:30 AM ET

  A Validation Study on the Impact of Decipher® Testing on Treatment Recommendations in African American and Non-African American Men with Prostate Cancer (VANDAAM STUDY)
  

  Presenter: Kosj Yamoah, MD, PhD – H. Lee Moffitt Cancer Center and Research Institute
• 8:30 AM – 8:40 AM ET

  Examination of Decipher Prostate Genomic Classifier in Patients with De Novo Metastatic Disease from a Large Scale Real-World Clinical and Transcriptomic Data Linkage
  

  Presenter: Shalini Moningi, MD – Brigham and Women's Hospital/Dana-Farber
• 8:40 AM – 8:50 AM ET

  The Interplay between Acute and Late Toxicity among Patients Receiving Prostate Radiotherapy: A Pooled Analysis of 7 Randomized Trials
  

  Presenter: John Nikitas, MD – UCLA Radiation Oncology
• 8:50 AM – 9:00 AM ET

  Prostate Cancer Integrated Risk Evaluation (P-CARE): A Model to Stratify Risk of Any, Metastatic, and Fatal Prostate Cancer
  

  Presenter: Anna Dornisch, MD – UC San Diego